Skip to main content

Research News

  • Amgen join with Roche on a phase 1b study to evaluate the safety and efficacy of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with Roche's investigational anti-PDL1 therapy, atezolizumab (also known as MPDL3280A), in patients with triple-negative breast cancer and colorectal cancer with liver metastases.

  • Researchers has found the mechanism whereby cancerous cells manage to spread from their original location to other parts of the body through the process known as metastasis.. A new study has found the mechanism of metastasis. Researchers compared the genetic material in the primary tumor's cells with the genetic material from metastasized cells in the same patient. They found that among all patient's genes, there is just one that clearly differs between those two groups. That gene, known as TBC1D16, in the initial tumor is inactive or dormant, while in the metastasized phase it is still active.

    [adsense:336x280:8701650588]

  • The growth of the Indian metallic packaging industry is highly dependent on the progress made by the overall economy. With the country’s economy doing fairly well, the retail sector booming, and consumer awareness on the recycling and environmental benefits of tinplate packaging rising, the outlook for the industry looks positive.

  • There has been a 16 per cent increase in daily generation of bio-medical waste in 2012-13 as against a marginal increase of 0.33 per cent the year ago, Lok Sabha was informed. Karnataka was the highest producer of bio-waste at 83,614 kg per day, followed by Maharashtra, which produced 65,660 kg of bio-wastes every day.

  • In the United States every year nearly 90,000 women are diagnosed with some gynecological cancer. These include cancer of the cervix, uterus, ovaries, vagina, and vulva. These women undergo treatments including radiation, chemotherapy and surgery. A University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015  has shown sexual dysfunction in women following gynecologic cancer treatment. The study shows decreased sexual activity in women following treatment for gynecologic cancers, down from 6.1-6.8 times per month before treatment to 2.6-4.9 times per month after treatment.

    [adsense:336x280:8701650588]

  • Merozyne Therapeutics AB has started a project goal to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A) by exploiting the unique research conducted by Prof. Madeleine Durbeej-Hjalt and Dr Virginie Carmignac at Lund University.

  • Biocartis and Fast-track diagnostics, have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla system. As part of the collaboration, tests from Fast-track diagnostics’ comprehensive infectious disease menu will be developed for use on Biocartis’ innovative molecular diagnostics (MDx) platform, Idylla. Idylla is a fully-automated MDx system that delivers accurate, rapid tests in virtually any setting, from virtually any biological sample type, and without the need for pre-processing or specialist training.

Subscribe to Research News